No Data
12 Health Care Stocks Moving In Monday's Pre-Market Session
Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares
Allarity Therapeutics Presents Phase 2 Clinical Data From Ongoing Trial In Advanced Ovarian Cancer Patients At The 2025 Annual Meeting For The Society Of Gynecologic Oncology
Express News | Allarity Therapeutics: Consented, Without Admitting or Denying SEC's Findings, to Entry of Administrative Cease-and-Desist Order
Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination With Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration
Allarity Therapeutics Announces Board Authorization of $5 Million Share Repurchase Program
102539778 : thats a nice chart setup
71370988 : it’s a long pending though